Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/14635
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.date.accessioned2023-08-16T17:01:37Z-
dc.date.available2023-08-16T17:01:37Z-
dc.date.issued2020-10-
dc.identifier.citationINSTITUTO NACIONAL DE CÂNCER (Brasil). Notas. Rede Câncer, Rio de Janeiro, v. 46, p. 31, out. 2020pt_BR
dc.identifier.urihttps://ninho.inca.gov.br/jspui/handle/123456789/14635-
dc.descriptionp. 31.: il. color.pt_BR
dc.language.isoporpt_BR
dc.publisherINCApt_BR
dc.subjectNeoplasias/tratamento farmacológicopt_BR
dc.subjectNeoplasms/drug therapypt_BR
dc.subjectNeoplasias/tratamiento farmacológicopt_BR
dc.subjectCOVID-19pt_BR
dc.subjectAnti-Inflamatóriospt_BR
dc.subjectAnti-Inflammatory Agentspt_BR
dc.subjectAntiinflamatoriospt_BR
dc.subjectImunoterapiapt_BR
dc.subjectImmunotherapypt_BR
dc.subjectInmunoterapiapt_BR
dc.titleNotaspt_BR
dc.title.alternativeRede Câncer 46pt_BR
dc.TypeArticlept_BR
Appears in Collections:Rede Câncer 46

Files in This Item:
File Description SizeFormat 
Notas.pdf135.19 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.